ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
17 oct. 2024 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to...
ClearPoint Neuro Announces Early Repayment of $10 Million Note
26 août 2024 16h05 HE
|
ClearPoint Neuro, Inc.
ClearPoint Neuro clears all debt from balance sheet after early repayment of principal & interest on $10 million convertible note held by PTC Therapeutics
ClearPoint Neuro Reports Second Quarter 2024 Results
07 août 2024 16h05 HE
|
ClearPoint Neuro, Inc.
ClearPoint Neuro reported Q2 2024 revenue of $7.9M, up 32% YoY, and raised full-year guidance to $30-33M #CLPT
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
17 juil. 2024 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to...
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
20 juin 2024 08h45 HE
|
ClearPoint Neuro, Inc.
ClearPoint® Navigation System to be used for all enrolled patients in Aspen's ASPIRO Parkinson's cell therapy clinical trial
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
01 juin 2024 09h00 HE
|
ClearPoint Neuro, Inc.
Newly Launched ClearPoint Neuro technology - SmartFrame OR and Prism Laser will be on display at ASSFN in Nashville from June 1 - 4
ClearPoint Neuro Reports First Quarter 2024 Results
07 mai 2024 16h05 HE
|
ClearPoint Neuro, Inc.
Q1-2024 Revenue Growth +41%, a Company Record
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
02 mai 2024 16h05 HE
|
ClearPoint Neuro, Inc.
Novel drug delivery research to be presented by ClearPoint Neuro Biologics team at ASGCT 2024 Annual Meeting in Baltimore
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
29 avr. 2024 08h00 HE
|
ClearPoint Neuro, Inc.
FDA Clearance of Prism Bone Anchor Accessory will expand use of the ClearPoint Prism® Neuro Laser Therapy to Operating Room
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
24 avr. 2024 16h05 HE
|
ClearPoint Neuro, Inc.
First 10 operating room procedures with SmartFrame OR successfully completed. Company expects positive impact to revenue in 2024 due to OR expansion.